The Efficacy and Safety of Liangxue Ointment in the Treatment of Hand-foot Syndrome Caused by VEGFR-TKI Drugs

This study was a prospective, single-center randomized controlled trial. The subject of this study is to evaluate the effectiveness and safety of traditional Chinese medicine Liangxue Ointment in the treatment of hand-foot syndrome caused by VEGFR-TKI drugs.

Trial Details

NCT ID
NCT06583369
Phase
NA
Sponsor
Peking University Cancer Hospital & Institute
Status
RECRUITING
Cancer Type
Melanoma
Interventions
  • Liangxue ointment（Traditional Chinese Ointment）
  • Urea cream
Locations (sample)
  • Beijing, China|39.9075,116.39723

Key Eligibility Criteria

  • ≥18 years old, both men and women are welcome;
  • Patients with pathologically confirmed malignant tumors;
  • Receive treatment with VEGFR-TKI drugs;
  • Hand-foot syndrome associated with VEGFR-TKI drugs is judged by the researcher;

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Melanoma Trials on Trialify →